Risk of type 2 diabetes mellitus after treatment with direct-acting antivirals for hepatitis C virus in people with HIV
Mathieu Chalouni(Harvard University), Sara Lodi(Boston University), Rachel Epstein(Boston University), Massimo Puoti(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), Johannes Nemeth(University of Zurich), Bernard Surial(University of Bern), Marina B. Klein(Royal Victoria Regional Health Centre), Christopher T. Rentsch(University of London), Juan Berenguer(Instituto de Salud Carlos III), Inmaculada Jarrín(Instituto de Salud Carlos III), Sophia M. Rein(Harvard University), Daniela K van Santen(Burnet Institute), Giota Touloumi(National and Kapodistrian University of Athens), Jessie Torgersen(Center for Clinical Research (United States)), Miguel A. Hernán(Harvard University), A. Papadopoulos(National and Kapodistrian University of Athens), Marc van der Valk(Academic Medical Center), Benjamin Linas, Anders Boyd, Antonella D'arminio Monforte, M John Gill, José M Miro, Jim Young, Roger Logan(Harvard University), Robert Zangerle, Linda Wittkop(Université de Bordeaux)
Cited by 0
Related Papers
Monkeypox Virus Infection in Humans across 16 Countries — April–June 2022
|New England Journal of Medicine|2022|2.2k
Effect of Early versus Deferred Antiretroviral Therapy for HIV on Survival
|New England Journal of Medicine|2009|1.1k
Vitamin D intake and incidence of multiple sclerosis
|Neurology|2004|1.1k
Factors Associated With Death in Critically Ill Patients With Coronavirus Disease 2019 in the US
|JAMA Internal Medicine|2020|1k
Observational Studies Analyzed Like Randomized Experiments
|Epidemiology|2008|814